Embecta AID System in Adults With Type 2 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford
Palo Alto, California, United States
- Diablo Research
Walnut Creek, California, United States
- Indiana Universtiy School of Medicine
Indianapolis, Indiana, United States
- Nyc Research
Long Island City, New York, United States
- Icahn School of Medicine at Mt. Sinai
New York, New York, United States
- Ut Southwestern
Dallas, Texas, United States
- Tekton Research
Irving, Texas, United States
- Texas Diabetes & Endocrinology
Round Rock, Texas, United States
- Dets Utah
Sandy City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2025
- Primary completion
- 31 Mar 2026
- Completion
- 31 May 2026
- Last update posted
- 16 Dec 2024
- Registered enrollment
- 0
- Registry id
- NCT06692153
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.